Chemical Conversions
Executive Summary
Interviews with the heads of R&D at a mid-sized drug firm (Ulrich Grau, BSAF Pharma) and a very large one (Wolfgang Hartwig, Bayer AG), both based in Germany, in which they discuss how their companies' research strategies are evolving in response to industry consolidation. Some Industry observers argue that pharmaceutical M&A has created entities of such massive scale that mid-sized organizations will soon be unable to compete. But Ulrich Grau argues that huge size is not an advantage in R&D because scientists tend to do their best work in small groups. He adds that BASF intends to leverage the flexibility its size enables to become more responsive to in-house research findings and to biotech partners it will seek out for the first time. Bayer thinks it can be more flexible than the industry's giants. To balance its chemical bent, Bayer has recently spent large sums to ally with partners whose technologies support work in 15 research areas.
You may also be interested in...
QUOTED. 22 January 2021. Neil Moat.
The Centers for Medicare and Medicaid Services has agreed to provide national Medicare coverage for mitral valve transcatheter edge-to-edge repair under a new coverage with evidence development policy. See what Neil Moat, chief medical officer for Abbott’s structural heart business, said about it here.
ICCR’s Growing Membership Ensures Diverse Cosmetics Regulatory Perspectives – PCPC
South Korea’s Ministry of Food and Drug Safety and Taiwan’s Food and Drug Administration will transition from ICCR observers to full members, joining regulatory authorities from the US, Europe, Japan, Canada and Brazil. PCPC’s Francine Lamoriello, EVP of global affairs, discusses.
Woodcock Faces Maze Of Rules To Become Commissioner Nominee
If Biden administration wants to nominate the acting commissioner, Vacancies Reform Act would dictate the timing. Woodcock can still get the nod and remain head of the agency during the confirmation process, just as Andrew von Eschenbach retained his acting title following his nomination in 2006.
Need a specific report? 1000+ reports available
Buy Reports